STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma.
Zhang P, Rashidi A, Zhao J, Silvers C, Wang H, Castro B, Ellingwood A, Han Y, Lopez-Rosas A, Zannikou M, Dmello C, Levine R, Xiao T, Cordero A, Sonabend AM, Balyasnikova IV, Lee-Chang C, Miska J, Lesniak MS.
Zhang P, et al. Among authors: han y.
Nat Commun. 2023 Mar 23;14(1):1610. doi: 10.1038/s41467-023-37328-9.
Nat Commun. 2023.
PMID: 36959214
Free PMC article.